MYUNGMOON Pharm co.,Ltd (017180.KS) KSC

Currency In KRW

AD

Valuation

Market Cap62.81B
Enterprise Value155.61B
P/E Ratio-21.09
PEG Ratio0.08
Price/Sales Ratio0.21
Price/Book Ratio0.44
Enterprise/Revenue0.53
Enterprise/EBITDA22.84

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.01
Operating Margin0.01
AD

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.02

Income Statement

Revenue195.25B
Revenue/Share5,977.7
Gross Profit107.19B
EBITDA10.13B
Net Income1.9B
Diluted EPS56.7

Balance Sheet

Total Cash24.31B
Total Cash/Share727.09
Total Debt87.15B
Total Debt/Equity0.89
Current Ratio1.06
Book Value Per Share3,070.44

Price History

52-Week Change-25.9
52-Week High2,055
52-Week Low1,000
Moving Average 50 Days1,217.18
Moving Average 200 Days1,554.53

Statistics

Average Volume523,116
Shares Outstanding33.43M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor513:500
Last Split DateMay 14, 2020
AD